H1N1 Vaccine Recalled in Canda After Severe Side-Effects
Tuesday, November 24, 2009 at 12:13PM Doctors have been advised to stop giving the H1N1 Vaccine in Canda after an unusually high number of reactions in patients occurred.
The reactions range from skin rashes, elevated heart rates, and dyspnea (difficulty breathing). About 1 in 20,000 people have had various anaphylactic reaction to the vaccine which is made by GlaxoSmithKline.
172,000 doses of SmiGlaxothKline's Aperanix vaccine are being recalled and the company has asked doctors to stop giving the vaccine to patients.
The company has declined to say at this time how many people have been given the vaccine at this time.
Aperanix vaccine, Canada, GSK, GlaxoSmithKline, H1N1, Swine Flu in Influenza, Vaccine Permalink Keith Erwood is the owner and Editor-in-Chief of the Disaster Preparedness Blog. Keith is a proven leader in business continuity management, disaster recovery planning, crisis leadership, and pandemic planning as well as other emergency management and preparedness mitigation issues. If you would like more information on how Keith can help you with your business continuity or disaster recovery planning please visit the Hire Me page for more information.
View Printer Friendly Version
Email Article to Friend
Reader Comments